Clinical Trials for Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Find clinical trials for chronic phase chronic myelogenous leukemia, bcr-abl1 positive. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Personalized NK Cell Therapy in CBT

NCT ID: NCT02727803

This clinical trial is looking at a new treatment called personalized natural killer (NK) cell therapy for patients with certain types of blood cancers, including leukemia, lymphoma, and myelodyspl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

NCT ID: NCT01746836

This clinical trial is looking at a medication called ponatinib hydrochloride to see how well it works for patients with chronic myeloid leukemia (CML) who haven't responded to or can't tolerate ot...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions